The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DIET2TREAT: A randomized, multi-center, phase 2 trial of a ketogenic diet vs standard dietary guidance in combination with standard-of-care treatment for patients with newly diagnosed glioblastoma.
 
LJ Amaral
Consulting or Advisory Role - Functional Formularies
 
Gillian Gresham
No Relationships to Disclose
 
Nicholas A. Butowski
Employment - University of California, San Francisco
Stock and Other Ownership Interests - Cordance; Cordance
Consulting or Advisory Role - IN8Bio; Ipsen; KIYATEC; Novartis; Plus Therapeutics; VBI Vaccines
Research Funding - Abbvie (Inst); Amgen; Amgen (Inst); Arbor Pharmaceuticals (Inst); BeiGene (Inst); BeiGene (Inst); BioMimetix (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); EpicentRx; Five Prime Therapeutics; Ipsen; Istari (Inst); KIYATEC (Inst); Medicenna; Merck; Oncoceutics (Inst); Orbus Therapeutics; Tocagen (Inst)
 
Katherine B. Peters
Consulting or Advisory Role - Anheart Therapeutics; Blue Earth Diagnostics; NuvOx Pharma; Ono Pharmaceutical; Rigel; Sapience Therapeutics; SERVIER; Telix Pharmaceuticals
Research Funding - Abbvie; BioMimetix; Novocure; Sapience Therapeutics; SERVIER; Varian Medical Systems
Other Relationship - Eisai Europe
(OPTIONAL) Uncompensated Relationships - Vivacitas Oncology
 
Akanksha Sharma
No Relationships to Disclose
 
Ekokobe Fonkem
Honoraria - Novocure
Consulting or Advisory Role - Novocure
Research Funding - Abbvie (Inst); Nativis (Inst); Novocure (Inst)
Patents, Royalties, Other Intellectual Property - Global Cancer Technology (Inst)
 
Jen-Tsan Chi
No Relationships to Disclose
 
Santosh Kesari
Stock and Other Ownership Interests - Curtana; Praesidia; xcures
Honoraria - Jubilant Biosys; Pyramid Biosciences
Consulting or Advisory Role - biocept; iCAD; xcures
Research Funding - AIVITA Biomedical, Inc. (Inst); Bayer (Inst); Biocept (Inst); Blue Earth Diagnostics (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Caris MPI (Inst); cns pharmaceuticals (Inst); EpicentRx (Inst); Lilly (Inst); Oblato (Inst); Orbus therapeutics (Inst)
 
Pao-hwa Lin
No Relationships to Disclose
 
Stephen Lawrence Shiao
Research Funding - Merck
 
Mourad Tighiouart
No Relationships to Disclose
 
Sungyong You
No Relationships to Disclose
 
Jeremy David Rudnick
No Relationships to Disclose
 
Stephen J. Freedland
Employment - Genomic Health (I)
Consulting or Advisory Role - A3P Biomedical; Astellas Pharma; AstraZeneca; Bayer; Caper Labs; Clovis Oncology; Dendreon; Exact Sciences; Exosome Diagnostics; Ferring; Hessian Labs; Janssen Biotech; LynxDx; Merck; Myovant Sciences; Pfizer; Sanofi; Tempus
Speakers' Bureau - AstraZeneca; Sanofi
Research Funding - Bayer (Inst); Diasorin; GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Merck; Myriad Genetics (Inst); OPKO Diagnostics (Inst); Progenika (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Jethro Lisien Hu
No Relationships to Disclose